The association of genetic polymorphisms with cerebral palsy: A meta-analysis

Developmental Medicine and Child Neurology

Volumn 53, Issue 3, 2011, Pages 217-225

  Wu, De ^a,b   Zou, Yan Feng ^a   Xu, Xiao Yan ^a   Feng, Xiao Liang ^a   Yang, Li ^a   Zhang, Gong Chun ^a   Bu, Xi Song ^a   Tang, Jiu Lai ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADDUCIN 1 ALPHA; ALPHA ADDUCIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BETA 2 ADRENERGIC RECEPTOR; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRINOGEN BETA POLYPEPTIDE; INTERLEUKIN 6; LYMPHOTOXIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYPEPTIDE; PROTHROMBIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BETA LYMPHOTOXIN ALPHA PRECURSOR; UNCLASSIFIED DRUG;

ARTICLE; CEREBRAL PALSY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); PRIORITY JOURNAL;

CEREBRAL PALSY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; POLYMORPHISM, GENETIC;

EID: 79551508888     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2010.03884.x     Document Type: Article

References (37)

1. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol 2007; 109(Suppl. 109): 8-14.
2. Stanley F, Blair E, Alberman E. Cerebral Palsies: Epidemiology and Causal Pathways. Clinics in Developmental Medicine, No. 151. London: Mac Keith Press, 2000.
3. Kuban KCK, Leviton A. Cerebral palsy. N Engl J Med 1994; 330: 188-95.
4. Nelson KB, Grether JK. Causes of cerebral palsy. Curr Opin Pediatr 1999; 11: 487-91.
5. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. N Engl J Med 1986; 315: 81-6.
6. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997; 278: 207-11.
7. Karin B, Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998; 44: 665-75.
8. Thorarensen O, Ryan S, Hunter J, Younkin DP. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis. Ann Neurol 1997; 42: 372-5.
9. Braga LW, Borigato EV, Speck-Martins CE, et al. Apolipoprotein E genotype and cerebral palsy. Dev Med Child Neurol 2010; 52: 666-71.
10. Wu YW, Croen LA, Torres AR, et al. Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants. Ann Neurol 2009; 66: 663-70.
11. Djukic M, Gibson CS, Maclennan AH, et al. Genetic susceptibility to viral exposure may increase the risk of cerebral palsy. Aust N Z J Obstet Gynecol 2009; 49: 247-53.
12. Clark EA. Association of candidate gene polymorphisms with death and cerebral palsy following preterm birth. Am J Obstet Gynecol 2009; 201: S263-4.
13. Gibson CS, MacLennan AH, Goldwater PN, et al. Mannose-binding lectin haplotypes may be associated with cerebral palsy only after perinatal viral exposure. Am J Obstet Gynecol 2008; 198: 509, e1-8.
14. McMichael GL, Gibson CS, Goldwater PN, et al. Association between apolipoprotein E genotype and cerebral palsy is not confirmed in a Caucasian population. Hum Genet 2008; 124: 411-6.
15. Kuroda MM, Weck ME, Sarwark JF, Hamidullah A, Wainwright MS. Association of apolipoprotein E genotype and cerebral palsy in children. Pediatrics 2007; 119: 306-13.
16. Gibson CS, MacLennan AH, Dekker GA, et al. Genetic polymorphisms and spontaneous preterm birth. Obstet Gynecol 2007; 109: 384-91.
17. Gibson CS, MacLennan AH, Goldwater PN, et al. The association between inherited cytokine polymorphisms and cerebral palsy. Am J Obstet Gynecol 2006; 194: 674, e1-11.
18. Yehezkely-Schildkraut V, Kutai M, Hugeirat Y, et al. Thrombophilia: a risk factor for cerebral palsy? Isr Med Assoc J 2005; 7: 808-11.
19. Gibson CS, MacLennan AH, Hague WM, et al. Associations between inherited thrombophilias, gestational age, and cerebral palsy. Am J Obstet Gynecol 2005; 193: 1437.
20. Fattal-Valevski A, Kenet G, Kupferminc MJ, et al. Role of thrombophilic risk factors in children with non-stroke cerebral palsy. Thromb Res 2005; 116: 133-7.
21. Nelson KB, Dambrosia JM, Iovannisci DM, et al. Genetic polymorphisms and cerebral palsy in very preterm infants. Pediatr Res 2005; 57: 494-9.
22. Meirelles KPB, Rodrigues CJ, de Barros TE, Bevilacqua RG. Presence of apolipoprotein E epsilon4 allele in cerebral palsy. J Pediatr Orthop 2000; 20: 786-9.
23. Gibson CS, Maclennan AH, Dekker GA, et al. Candidate genes and cerebral palsy: a population-based study. Pediatrics 2008; 122: 1079-85.
24. Gibson C, MacLennan A, Hague B, et al. Fetal thrombophilic polymorphisms are not a risk factor for cerebral palsy. Am J Obstet Gynecol 2003; 189: S75.
25. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 629-34.
26. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101-29.
27. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
28. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-48.
29. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
30. Beger C, Berlin JA. Publication bias: a problem in interpreting medical data. J R Stat Soc A 1988; 151: 419-63.
31. Brull DJ, Montgomery HE, Sanders J, et al. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001; 21: 1458-63.
32. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-76.
33. Kilpinen S, Hulkkonen J, Wang XY, Hurme M. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Eur Cytokine Netw 2001; 12: 62-8.
34. Iwamoto S. Are promoter polymorphisms of interleukin 6 ready to be applied in genetic markers of cardiovascular diseases? Hypertens Res 2007; 30: 575-6.
35. Harding DR, Dhamrait S, Whitelaw A, et al. Does interleukin-6 genotype influence cerebral injury or developmental progress after preterm birth? Pediatrics 2004; 114: 941-7.
36. Jarvis S, Glinianaia SV, Arnaud C, et al. Case gender and severity in cerebral palsy varies with intrauterine growth. Arch Dis Child 2005; 90: 474-9.
37. Greenland S. Can meta-analysis be salvaged? Am J Epidemiol 1994; 140: 783-7.